ℹ️
🇬🇧
Search
Search for publications relevant for "EDSS score"
EDSS score
Publication
Class
Person
Publication
Programmes
publication
Real-world effectiveness and safety of fingolimod in patients with multiple sclerosis in the Czech Republic: results from core and extension parts of the GOLEMS study up to 48 months
2022 |
First Faculty of Medicine
publication
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
2012 |
First Faculty of Medicine
publication
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
2017 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Neuromyelitis Optica Spectrum Disorders - Retrospective Analysis of Clinical and Paraclinical Findings
2015 |
First Faculty of Medicine
publication
Predictors of Long-Term Disability Accrual in Relapse-Onset Multiple Sclerosis
2016 |
First Faculty of Medicine
publication
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
2023 |
First Faculty of Medicine
publication
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study
2012 |
First Faculty of Medicine
publication
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study
2012 |
Second Faculty of Medicine
publication
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years
2020 |
First Faculty of Medicine
publication
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals
2021 |
First Faculty of Medicine
publication
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis : A Subgroup Analysis From Three International Cohorts
2021 |
First Faculty of Medicine
publication
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
2021 |
Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
publication
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
2023 |
First Faculty of Medicine
publication
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome
2012 |
First Faculty of Medicine
publication
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
2022 |
First Faculty of Medicine
publication
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
2020 |
First Faculty of Medicine
publication
Hematopoietic stem cell transplatation for multiple scerosis: A retrospective multicenter study
2002 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
2019 |
First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
publication
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
2017 |
First Faculty of Medicine
publication
Early clinical markers of aggressive multiple sclerosis
2020 |
First Faculty of Medicine
publication
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Measurement of Corpus Callosum and Comparison of MRI Techniques for Monitoring of Multiple Sclerosis
2012 |
First Faculty of Medicine
publication
Hematopoietic stem cell transplantation for multiple sclerosis
2005 |
Third Faculty of Medicine
publication
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
2018 |
First Faculty of Medicine
publication
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
2018 |
First Faculty of Medicine
publication
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
2019 |
First Faculty of Medicine
publication
Reduced bone mineral density in women with multiple sclerosis
2013 |
First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis
2021 |
First Faculty of Medicine
publication
Is breastfeeding in MS harmful or not? An answer from real-world Czech data
2023 |
First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
publication
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network
2023 |
First Faculty of Medicine